“What’s really driving the interest around the phenomenon that we currently label as GLP-1s?”

In this episode of Pharmland, hosts Bradley Nelson and Tom Davies dive deep into the world of GLP-1 medications for weight loss alongside RxBenefits clinical pharmacist Langley Kyle, PharmD. They tackle pressing questions surrounding the surge in GLP-1 utilization, from the impact of direct-to-consumer marketing and celebrity endorsements to concerns about sustainability and potential side effects. Join them as they unravel the complexities of this pharmaceutical phenomenon and explore whether the promises made by these medications truly stand up to scrutiny.

You can also subscribe to any of these podcast platforms to receive notifications on new episodes.